BBA
VOR icon

Baker Bros. Advisors’s Vor Biopharma VOR Stock Holding History

Baker Bros. Advisors’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-31,692
Closed -$1.34M – 101
2023
Q3 		$1.34M Hold
31,692
– – 0.01% 94
2023
Q2 		$1.96M Hold
31,692
– – 0.01% 97
2023
Q1 		$3.41M Sell
31,692
-41,604
-57% -$4.61M 0.02% 80
2022
Q4 		$9.75M Hold
73,296
– – 0.06% 59
2022
Q3 		$5.83M Buy
73,296
+16,358
+29% +$1.61M 0.04% 73
2022
Q2 		$5.66M Buy
+56,938
New +$5.83M 0.03% 78

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return